Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
Clinical trial NCT00454051 · COMPLETED
Trial details
- NCT number
- NCT00454051
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-03-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.